This work details the study of the redox behavior of the drugs cyclobenzaprine (CBP), amitriptyline (AMP) and nortriptyline (NOR) through voltammetric methods and computational chemistry. Results obtained in this study show that the amine moiety of each compound is more likely to undergo oxidation at 1a at Ep1a ≈ 0.69, 0.79, 0.93 V (vs. Ag/AgCl/KClsat) for CBP, AMP and NOR, respectively. Moreover, CBP presented a second peak, 2a at Ep2a ≈ 0.98 V (vs. Ag/AgCl/KClsat) at pH 7.0. Furthermore, the electronic structure calculation results corroborate the electrochemical assays regarding the HOMO energies of the lowest energy conformers of each molecule. The mechanism for each anodic process is proposed according to electroanalytical and computational chemistry findings, which show evidence that the methods herein employed may be a valuable alternative to study the redox behavior of structurally similar drugs.
Electrocatalysis is a promising way to treat water contaminated by harmful organic compounds. The combination of nanoparticles supported on a conductive substrate allows degradation to occur under less energetic conditions. This work evaluated the effect of deposition of bismuth vanadate (BVO) particles on pencil-type graphite electrodes. BVO particles were obtained by ultrasonic irradiation with coprecipitation. Then, they were deposited on the surface of a graphite electrode by the impregnation method. A 23-design was used to optimize electrode fabrication. Matter Dispersion Spectroscopy (SEM/EDS), X-Ray Diffraction (XRD) and Dynamic Light Scattering (DLS) were used for characterization. Electrochemical characterization was performed by electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV). The results confirmed the synthesis of BVO@C (BVO/graphite). Furthermore, BVO@C significantly increased the electroactive surface area of the electrode, decreased the electron transfer resistance, and significantly increased the electron transfer rate to a greater extent than the electrode without any modification. To prove that the performance of BVO@C is better than the pure electrode, photoelectrocatalysis (PEC) and electrocatalysis (EC) were performed in a rhodamine B (RhB) solution. The results showed that in 5 min of treatment with unmodified electrode, BVO@C EC system and BVO@C PEC system, there was degradation of 31.53%, 46.09% and 58.17% respectively, reaching 95%, 98% and 99.64%, respectively, in 30 min. The reaction rate constants were calculated and to be found k = 0.10272 m−1, k = 0.12221 m−1 and k= 0.15022 m−1 for the unmodified graphite, BVO@C EC System and BVO@C PEC system, respectively. These results demonstrate that the BVO@C electrodes are efficient for application in a wide range of treatments, including the treatment of organic pollutants.
Gatifloxacin (GAT), a fourth-generation antimicrobial agent, requires stringent quality control measures in human medication. Electroanalysis offers a cost-effective method for quality control, showing promise for drug analyses. In this study, GAT eye drops were analyzed using differential pulse voltammetry (DPV) with a BiVO4-modified carbon paste electrode (CPE). The electrochemical characterization of GAT involved a pH study, determining pH 7.0 as optimal with an anodic oxidation process at 0.88 V. The anodic peak suggested equivalence between protons and electrons, with a Nernstian-like slope of around 59 mV. pH-1 in the Epa vs. pH plot. Subsequent assays using PBS at pH 7.0 showed promising results. The electroanalytical method exhibited precision and accuracy that were suitable for the intended purpose. CPE/BiVO4 provided a low-cost, versatile, and rapid alternative for GAT quantification in pharmaceutical formulations, indicating the potential for analyzing other drugs in complex matrices. Subsequent voltammetric assays were carried out using PBS at pH 7.0. Further tests demonstrated a linear correlation between GAT concentration and current intensity (r2 = 0.99), with an LOD of 0.07 µM and LOQ of 0.23 µM. Precision testing confirmed the method’s reliability, showing a relative standard deviation of 1.28% and 1.48% for intra-day and inter-day precision, respectively. The CPE/BiVO4 method proved accurate, precise, and reproducible, offering a low-cost and versatile alternative for GAT quantification in pharmaceutical formulations. The findings suggest the potential application of this electroanalytical approach for drug analysis in complex biological matrices, showing promise for the quantification of other pharmaceuticals.